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be fully clarified. The increased cyto-
plasmic concentrations of fumarate or
succinate substrates, due to low or
absent FH/SDH activity, inhibit the
degradation of HIF. Persistence of HIF
induces activation of sustained hypoxic
response signals, which are considered
to be involved in hypervascularization
or neoplastic growth (Pollard, 2005).
However, some major questions still
remain unanswered. Why, for example,
do mutations in FH, SDH or VHL genes,
that are components of the same path-
way of hypoxia detection, cause differ-
ent tumors? Moreover, as a unique
mutation should lead to a unique
phenotype, could the specific duplica-
tion of exon 7, which we detected in
this family, be in some way related to
cerebral cavernomas? To our knowl-
edge this is the first time that cerebral
angiomatous lesions are described in
MCUL patients. We believe that this
finding adds new insight into the
genetic background of this syndrome,
suggesting that a reassessment of the
overall clinical spectrum of MCUL
might be required.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank Dr Marco Ranalli for setting up the
biochemical test for FH activity; Professor Richard
Knight (MRC, Toxicology Unit, Leicester, UK) for
proofreading the manuscript and for helpful
suggestions and discussions. We also thank Diana
Saltarelli for editing this paper. This work was
partially supported by EU-Grants EPISTEM (LSHB-
CT-019067), FIRB-Grants RBNE01KJHT_004,RB-
NE01NWCH_008; MIUR/PRIN 004064744_003;
AIRC rif. 1338; ISS n. 530/F-A19. The work was
also supported by Grant Telethon GGPO4110 to
Gerry Melino.
Elena Campione1,5, Alessandro
Terrinoni2,5, Augusto Orlandi3,
Andrea Codispoti2, Gerry Melino2,
Luca Bianchi1, Annamaria Mazzotta1,
Francesco Giuseppe Garaci4,
Andrea Ludovici4 and Sergio Chimenti1
1Department of Dermatology, University of
Rome ‘‘Tor Vergata’’, Rome, Italy; 2IDI-IRCCS.
Biochemistry Laboratory, c/o Department of
Experimental Medicine, University of Rome
‘‘Tor Vergata’’, Rome, Italy; 3Department of
Pathology, University of Rome ‘‘Tor Vergata’’,
Rome, Italy and 4Department of Internal
Medicine, Diagnostic Imaging, University of
Rome ‘‘Tor Vergata’’, Rome, Italy
E-mail: a.terrinoni@idi.it
5These two authors contributed equally to the
work
REFERENCES
Baysal BE (2000) Mutations in SDHD, a mito-
chondrial complex II gene, in hereditary
paraganglioma. Science 287:848
Bourgeron T, Chretien D, Poggi-Bach J, Doonan S,
Rabier D, Letouze P et al. (1994) Mutation of
the fumarase gene in two siblings with
progressive encephalopathy and fumarase
deficiency. J Clin Invest 93:2514–8
Garman ME, Blumberg MA, Ernst R, Raimer SS
(2003) Familial leiomyomatosis: a review
and discussion of pathogenesis. Dermatology
207:210–3
Hatch MD (1978) A simple spectrophotometric
assay for fumarate hydratase in crude tissue
extracts. Anal Biochem 85:271–5
Holst VA, Junkins-Hopkins JM, Elenitsas R (2002)
Cutaneous smooth muscle neoplasms: clin-
ical features, histologic findings, and treat-
ment options. J Am Acad Dermatol
46:477–90; quiz, 491–474
Kim WY, Kaelin WG (2004) Role of VHL gene
mutation in human cancer. J Clin Oncol
22:4991
Kiuru M, Launonen V, Hietala M, Aittomaki K,
Vierimaa O, Salovaara R et al. (2001)
Familial cutaneous leiomyomatosis is a two-
hit condition associated with renal cell
cancer of characteristic histopathology. Am
J Pathol 159:825–9
Niemann S, Muller U (2000) Mutations in SDHC
cause autosomal dominant paraganglioma,
type 3. Nat Genet 26:268–70
Pollard PJ (2005) Accumulation of Krebs cycle
intermediates and over-expression of HI-
F1[alpha] in tumors which result from germ-
line FH and SDH mutations. Hum Mol Genet
14:2231
Tomlinson IP, Alam NA, Rowan AJ, Barclay E,
Jaeger EE, Kelsell D et al. (2002) Germline
mutations in FH predispose to dominantly
inherited uterine fibroids, skin leiomyomata,
and papillary renal cell cancer. Nat Genet
30:406–10
Toro JR (2003) Mutations in the fumarate hydra-
tase gene cause hereditary leiomyomatosis
and renal cell cancer in families in North
America. Am J Hum Genet 73:95
A Novel S115G Mutation of CGI-58 in a Turkish Patient
with Dorfman–Chanarin Syndrome
Journal of Investigative Dermatology (2007) 127, 2273–2276; doi:10.1038/sj.jid.5700860; published online 10 May 2007
TO THE EDITOR
Dorfman–Chanarin syndrome (DCS:
OMIM No. 275630), also referred to
as neutral lipid storage disease, is a
recessive disorder characterized by
ichthyosiform erythroderma variably
associated with liver steatosis, muscle
weakness, neurosensory deafness, and
subcapsular cataracts. DCS is asso-
ciated with accumulation of lipid
vacuoles in many tissues (Chanarin
et al., 1975) and related to a blockage
in the catabolism of triacylglycerol (Igal
and Coleman, 1996). We previously
demonstrated that mutations in a new
gene CGI-58 underlie DCS (Lefe`vre
et al., 2001). In this study, we report
a novel mutation of CGI-58 (S115G)
in a patient with DCS of Turkish
origin.
An 18-month-old Turkish girl was
referred to a department of haemato-
logy for workup of splenomegaly. At
birth, she presented with fine scales and
erythema over her entire body, consis-
tent with congenital non-bullous
ichthyosiform erythroderma. At age 18
months, multiple laboratory abnormal-
ities were present: elevated liver
enzymes related to hepatic steatosis
Abbreviations: ATGL, adipose triglyceride lipase; DCS, Dorfman–Chanarin syndrome; OMIM, Online
Mendelian Inheritence in Man; RT-PCR, reverse transcription-PCR
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and fibrosis, raised levels of muscle
enzymes, lipid vacuoles in leukocytes
(Figure 1a), and in precursor myeloid
cells in blood and bone marrow smears.
Light microscopy of skin biopsy re-
vealed parakeratosis, and lipid droplets
were seen in keratinocytes by electron
microscopy in accordance with DCS
(Figure 1b). Her consanguineous par-
ents, two sisters, and one brother were
free from ichthyosis, and examination
of their granulocytes revealed no
vacuoles.
We searched for CGI-58 mutation in
the patient, her parents, two sisters, and
one brother. These studies were con-
ducted according to the Declaration of
Helsinki Principles. The patient’s par-
ents gave their written informed con-
sent. The medical ethical committee of
the Dokuz Eylu¨l University approved
all described studies. Genomic DNA
was isolated from peripheral blood and
subjected to PCR amplification, fol-
lowed by direct sequencing using an
ABI PRISM 3100 genetic analyzer
(Applied Biosystems, Courtaboeuf,
France). The oligonucleotide primers
and PCR conditions used have been
previously described (Lefe`vre et al.,
2001). Both DNA strands from the
proband, her family members, and 49
healthy Turkish controls were entirely
sequenced for the seven exons and for
the intron/exon boundaries of CGI-58.
In the patient, a homozygous A-to-G
transition in exon 3 at position 343 was
identified (Figure 1c). It was present at a
heterozygous state in both parents
(Figure 1c) and her brother. This
343A4G transition, which has not
been previously reported, was neither
found in both sisters nor in 49 normal
Turkish subjects. To determine if this
nucleotide variation altered splicing of
mRNA, we performed in silico splice
site analysis (https://splice.cmh.edu),
which predicted the appearance of a
cryptic splice site at nucleotide 344
(Figure 2a). Reverse transcription-PCR
(RT-PCR) experiments using a forward
primer from exon 3 and reverse primers
from exons 3 and 6 refuted this predic-
tion showing a normal size for both
CGI-58 transcripts (Figure 2b). This
343A4G transition substituted serine
for glycine at position 115 (S115G).
This novel S115G mutation was neither
found in both sisters of the patient nor
in 98 unrelated Turkish alleles, and was
unlikely to be a polymorphism. In
addition, several data suggested that
the S115G mutation may have func-
tional consequences. It changed a polar
(serine) for an apolar (glycine) amino
acid; this serine 115 is the first amino
acid of a motif [S/T]- -[R/K] predicting
to be a site of protein kinase C
phosphorylation (Woodgett et al.,
1986). In addition, conversion of serine
115 to glycine would be expected to
affect the conformation of CGI-58
protein since in silico analysis (http://
bioweb.pasteur.fr) predicted a structural
change of leucine 110 from coil to
a b
c Reverse strand sequence
Patient Sister Father Mother
Figure 1. Lipid vacuoles in granulocytes and keratinocytes and CGI-58 mutation in the DCS patient. (a) Peripheral blood smear revealed cytoplasmic
lipid droplets (arrow) in granulocytes (Jordans’ anomaly). Bar¼ 2.5 mm. (b) Ultrastructural analysis of skin biopsy demonstrated lipid droplets devoid of
membrane in keratinocytes. Bar¼ 2 mm. (c) Sequence analysis of CGI-58 revealed a homozygous missense mutation (343A4G in exon 3 leading to S115G)
in the patient, a heterozygous mutation in both parents, and a normal sequence in a sister (sequencing of the reverse strand; GenBankTM accession
numbers: AF151816).
2274 Journal of Investigative Dermatology (2007), Volume 127
ZB Selma et al.
CGI-58 Mutation in Dorfman–Chanarin Syndrome
sheet (Figure 2c) (Frishman and Argos,
1997). Moreover, CGI-58 amino-acid
sequence alignment demonstrated that
serine 115 is highly conserved among
all studied species (Figure S1). Conser-
vation of serine 115 was also observed
among five of the family members
of CGI-58 (ABHD 4, 8, 9, 10, and 12)
(data not shown). Finally, recent func-
tional analyses demonstrated that a
close mutation (Q130P) induces an
intracytoplasmic mislocalization of
CGI-58, that is, abolition of recruitment
of CGI-58 to lipid droplets in rat
adipocytes and HeLa cells. Also, the
Q130P mutated protein lost its ability to
interact with perilipin, a partner located
at the surface of lipid droplets (Yama-
guchi et al., 2004). Ultimately, CGI-58
has recently been identified as a coac-
tivator of adipose triglyceride lipase
(ATGL) and the Q130P mutation com-
pletely abrogated this function of coac-
tivation (Lass et al., 2006). All these
findings strongly suggest that the S115G
missense mutation alters both CGI-58
structure and function.
The CGI-58 gene is located on 3p21,
has seven exons, and its mRNA is
expressed in many tissues including
skin. Recently, we described eight dis-
tinct mutations of CGI-58 in 13 patients
with DCS of nine families from various
countries (Lefe`vre et al., 2001). To date,
only seven additional mutations in five
patients have been reported (Akiyama
et al., 2003; Srinivasan et al., 2004;
Pujol et al., 2005; Schleinitz et al., 2005;
Lass et al., 2006). These mutations were
distributed worldwide and homozygous
in all cases except compound hetero-
zygous in two patients. They included
five missense mutations, five nonsense
mutations, two splice site mutations, one
insertion, one deletion, and one inser-
tion/deletion. In the Turkish population,
only two mutations including an E260K
missense mutation and an insertion
(594insC) leading to premature stop
codon at position 209 were reported
(Lefe`vre et al., 2001). We described here
a third mutation, S115G, hence exclud-
ing a founder effect in Turkish patients
with DCS.
CGI-58 is a 349-amino-acid protein
coactivating a newly identified lipase,
ATGL, which hydrolyzes triacylglycerol
to yield diacylglycerol and fatty acid
(Lass et al., 2006). Thus, CGI-58 muta-
tions abrogated lipolysis and induced a
systemic accumulation of lipids dro-
plets. In epidermis, lipids vacuoles
were associated with a defective for-
mation of lamellar granules (Akiyama
et al., 2003). Lipid microinclusions in
lamellar granules formed a non-lamel-
lar phase within the stratum corneum
interstices and may explain the perme-
ability barrier abnormality (Demerjian
et al., 2006).
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Figure 2. Consequences of the CGI-58 mutation on splicing and secondary structure and sequence
alignments around serine 115. (a) In silico analysis of the 343A4G transition showed an increase of the
Ri value from 0.8 to 3.9, predicting the appearance of a cryptic splice site one nucleotide after the
mutation (https://splice.cmh.edu). (b) RT-PCR using the forward primer from exon 3 (nucleotides
246–265) and the reverse primers from exon 3 (nucleotides 443–462) (lanes 1 and 2) and from exon 6
(nucleotides 922–941) (lanes 3 and 4) produced respectively a 217-bp and a 696-bp fragments, which
were similar in the patient (lanes 2 and 4) and in a control (lanes 1 and 3). Molecular weight markers were
in lane 5. (c) In silico analysis of the conversion of serine 115 to glycine (arrow) predicted a structural
change (arrowhead) of leucine 110 from coil (_) to sheet (E) (http://bioweb.pasteur.fr). H designated helix
structure.
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We reported here the finding of a
new pathogenic CGI-58 mutation in a
Turkish patient with DCS. This S115G
mutation further illustrates the functional
importance of CGI-58 in lipid metabo-
lism and epidermal differentiation.
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SUPPLEMENTARY MATERIAL
Figure S1. CGI-58 amino-acid sequence align-
ment in 13 species (ClustalW).
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TO THE EDITOR
Psoriasis vulgaris is a common chronic
inflammatory skin disease, possibly of
autoimmune etiology, and character-
ized by erythematous, scaly lesions
with a predilection for the scalp and
extensor surfaces of the extremities,
whereas the palms and soles are usually
not primarily involved.
The inflammation is manifested by
vasodilation, with infiltrates of T lym-
phocytes, mainly CD4þ in the papillary
dermis and CD8þ in the epidermis. In
the papillary dermis there is also an
increased number of mast cells (Harvi-
ma et al., 1993), natural killer (NK) cells
(Cameron et al., 2002) and plasma-
cytoid dendritic cells (Nestle et al.,
2005), the latter producing large
amounts of IFNa, which is now con-
sidered to be of particular relevance for
initiation of the inflammation. Migra-
tion of neutrophil granulocytes into the
epidermis, with formation of micro-
abscesses, is another typical feature.
The possibility of dysregulation of
innate immunity in psoriasis is currently
under discussion (Bos et al., 2005).
Although there is evidence that psoria-
sis is an autoimmune disease, few, if
any, autoantigens have been defined and
no psoriasis-specific antigen has been
found (reviewed in Bos et al., 2005). To
reveal antigens recognized by T lympho-
cytes in human disease has been found
to be a difficult task. There is, however,
an interaction between T cells and B
cells in autoimmune diseases. Antigen-
specific autoreactive T lymphocytes
(Th2) play a central role in autoimmu-
nity, in which they activate B cells to
produce antibodies (Nishifuji et al.,
2000). Hence, identification of autoanti-
bodies against potential psoriasis-related
antigens would also yield important
knowledge regarding T-cell-mediated
mechanisms in this disease.
We have tried to identify autoanti-
gens in psoriasis by recombinant ex-
pression cloning, a method which is
well established in our laboratory and
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